**Question:** The drug of choice in choriocarcinoma is:

A. Methotrexate
B. Cisplatin
C. Paclitaxel
D. Cyclophosphamide

**Core Concept:** Choriocarcinoma is a type of gestational trophoblastic neoplasia, which develops from the abnormal proliferation of cells in the placenta. It is characterized by the production of human chorionic gonadotropin (hCG) and can lead to life-threatening complications like pulmonary hypertension and cerebral oedema.

**Why the Correct Answer is Right:** Methotrexate is a folic acid analogue that inhibits the enzyme dihydrofolate reductase, leading to depletion of tetrahydrofolate and DNA synthesis inhibition. This is useful in treating choriocarcinoma because high levels of hCG are produced in response to the tumor burden, and methotrexate can target these cells directly.

**Why Each Wrong Option is Incorrect:**

B. Cisplatin (platinum-based chemotherapeutic agent) does not specifically target choriocarcinoma cells, although it may have some activity against the tumor.

C. Paclitaxel (antimicrotubule agent) is effective against several types of cancer but is not specifically tailored to treat choriocarcinoma.

D. Cyclophosphamide (anthracycline antibiotic) has some activity against choriocarcinoma but is not the first-choice agent due to its broad spectrum activity and potential for causing side effects.

**Why Each Wrong Option is Incorrect:**

Paclitaxel (antimicrotubule agent) is effective against several types of cancer but is not specifically tailored to treat choriocarcinoma.

Cyclophosphamide (anthracycline antibiotic) has some activity against choriocarcinoma but is not the first-choice agent due to its broad spectrum activity and potential for causing side effects.

Cisplatin (platinum-based chemotherapeutic agent) does not specifically target choriocarcinoma cells, although it may have some activity against the tumor.

Methotrexate (folic acid analogue) is the correct answer as it specifically targets high hCG-producing choriocarcinoma cells through inhibition of dihydrofolate reductase enzyme, leading to DNA synthesis inhibition.

**Clinical Pearls:**

- Choriocarcinoma is a rare but potentially life-threatening complication of pregnancy.
- Monitoring hCG levels is crucial for assessing treatment response and adjusting the dosage of methotrexate accordingly.
- The choice of chemotherapy regimen depends on factors like the stage of the disease, patient's age, and overall health status.

**Why Each Wrong Option is Incorrect:**

Paclitaxel and cyclophosphamide are used in other cancer treatment regimens but are not specifically targeted at choriocarcinoma cells.

Cisplatin has some activity against choriocarcinoma, but its mechanism of action is distinct from methotrexate's targeting of hCG-producing cells.